TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover |
2,116
|
691
|
368 |
Financial expenses |
0
|
1
|
0 |
Earnings before taxes |
209
|
-677
|
-726 |
EBITDA |
214
|
-673
|
-725 |
Total assets |
9,146
|
9,941
|
5,806 |
Current assets |
3,235
|
4,382
|
1,070 |
Current liabilities |
646
|
922
|
623 |
Equity capital |
8,500
|
9,019
|
5,184 |
- share capital |
241
|
263
|
208 |
Employees (average) |
10
|
9
|
8 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency |
92.9%
|
90.7%
|
89.3% |
Turnover per employee |
212
|
77
|
46 |
Profit as a percentage of turnover |
9.9%
|
-98.0%
|
-197.3% |
Return on assets (ROA) |
2.3%
|
-6.8%
|
-12.5% |
Current ratio |
500.8%
|
475.3%
|
171.7% |
Return on equity (ROE) |
2.5%
|
-7.5%
|
-14.0% |
Change turnover |
1,482
|
329
|
262 |
Change turnover % | 233% | 247% | |
Chg. No. of employees |
1
![]() |
1
|
-1 |
Chg. No. of employees % | 11% | -11% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.